Spain-based contract research organisation (CRO) Sofpromed has selected TrialMaster as its preferred electronic data capture (EDC) system to support the company’s clinical data management services.
Sofpromed CEO Patricio Ledesma said: “As an oncology-focused CRO, we are pleased to provide Omnicomm’s TrialMaster EDC solution to our customers, particularly to pharma and biotech companies conducting phase I-IV clinical studies for the development of cancer drugs in the United States and Europe.
“The TrialMaster EDC Suite will greatly enrich and strengthen our data management and statistical programming services for clinical trials. Sponsors will benefit from solid, high-quality clinical data, while investigators and study coordinators will certainly value TrialMaster’s intuitive design and ease of use.”
Sofpromed also provides oncology-focused clinical trial services to support the study of solid tumours and hematologic malignancies for the pharmaceutical and biotechnology fields.
With its oncological, technical and regulatory expertise, the company seeks to enable the acceleration of study start-up, recruitment, and data anlaysis to its customers.
Data management and reporting features in TrialMaster plays a major role in supporting Sofpromed’s operations.
OmniComm Systems EMEA region business development senior vice-president Rohit Mistry said: “We are delighted to partner with Sofpromed to conduct their oncology trials. The studies they conduct are complex in nature, requiring an EDC that provides flexibility, yet still very intuitive for sites globally to use.
“With the support of our European delivery team, Sofpromed is now enabled to incorporate TrialMaster study build services into their core services, offering sponsors their oncological expertise coupled with the most innovative EDC solution on the market.”
In March this year, OmniComm Systems signed an agreement with German academic centre KKS (Coordination Center for Clinical Trials) for TrialMaster EDC technology.